Background Immunotherapy is vital in the comprehensive treatment of gastric cancer (GC).
However, the prognosis of GC patients remains unfavorable, necessitating to exploration of …

e16056 Background: Immunotherapy is vital in the comprehensive treatment of gastric
cancer (GC). However, the prognosis of GC patients remains unfavorable, necessitating to …

Aim: Colorectal cancer (CRC) is the leading cause of cancer associated death worldwide
and immune checkpoint blockade therapy only benefit a small set of CRC patients. Tumor …

Background The aims of the study was to reveal the mechanisms of SLC7A9 regulating
ferroptosis in gastric cancer cells and explore new treatment strategies for gastric cancer …

Background: Liver hepatocellular carcinoma (LIHC) is a complicated disease with poor
survival and lack of viable treatment options. The roles of ferroptosis and immunotherapy in …

Ferroptosis is a cell death process caused by metabolic dysfunction with the feature of
aberrant iron accumulation. Emerging studies have identified that ferroptosis is an important …

SLC2A3 is a ferroptosis marker engaged in transmembrane glucose transport. However, the
effect of SLC2A3 on the prognosis of patients with cancer remains unclear. This study aimed …

Gastric cancer (GC) is one of the most common gastrointestinal malignancies. Ferroptosis is
a new type of peroxidation‐driven and iron‐dependent cell death. However, the biological …

ABSTRACT Background/Aims: Inflammation is an essential driver of colorectal cancer
(CRC). Identifying phenotypes and targets associated with inflammation and cancer may be …

Gastric cancer (GC) is a malignant disease of the digestive tract and a life-threatening
disease worldwide. Ferroptosis, an iron-dependent cell death caused by lipid peroxidation …